# Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole

> **NCT03218657** · NA · UNKNOWN · sponsor: **Shengyun Lin** · enrollment: 248 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** levamisole hydrochloride
- **DRUG:** Androgens
- **DRUG:** Cyclosporins

## Key facts

- **NCT ID:** NCT03218657
- **Lead sponsor:** Shengyun Lin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2017-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03218657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03218657, "Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03218657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*